两个心脏生物标志物在IgA脏病中的作用
Balázs Sági1,2, Tibor Vas1, Rita Jakabfi-Csepregi3,4
12nd. Department of Internal Medicine and Nephrology, Diabetes Center, Clinical Center, Medical School, University of Pécs, 7624 Pécs, Hungary.
International journal of molecular sciences
|June 28, 2023
概括
生物标志物,如脑性尿素 (NT-proBNP) 的N终端前激素和I型原体的碳氧终端端 (CITP),可以识别高风险心力衰竭和动脉样硬化疾病的IgA脏病患者.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 生物标志物发现发现
背景情况:
- 心血管死亡率是慢性病 (CKD) 的一个主要问题,特别是IgA脏病 (IgAN).
- 在IGAN患者中评估心血管风险需要确定可靠的生物标志物,以便早期检测心脏和血管变化.
- 动脉硬和心脏功能是影响CKD患者结果的关键因素.
研究的目的:
- 调查大脑尿素 (NT-proBNP) 的N终端前激素和I型原体的卡基终端端 (CITP) 在IGAN患者中作为生物标志物的实用性.
- 将这些生物标志物与心血管健康指标相关联,包括动脉硬和心脏功能.
- 根据慢性病 (CKD) 阶段区分生物标志物水平.
主要方法:
- 90名Igan患者的横截面研究,根据估计的淋巴细胞过率 (eGFR) 分类为CKD 1-2和3-5阶段.
- 测量NT-proBNP (心力衰竭生物标志物) 和CITP (纤维化标志物).
- 评估动脉硬性通过带 - 椎脉冲波速 (cfPWV),中央大动脉缩压,并通过例行心声回声.
主要成果:
- 与CKD 3-5组的患者相比,CKD 1-2组的患者表现出明显更高的NT-proBNP,cfPWV和中央大动脉缩压.
- 在先进的CKD组中,NT-proBNP和CITP阳性率都显着更高.
- eGFR与NT-proBNP呈现强烈的负相关性,而cfPWV和LVMI与NT-proBNP和CITP均呈现正相关性.
结论:
- NT-proBNP和CITP显示出作为生物标志物的潜力,用于识别患有亚临床心力衰竭高风险的Igan患者.
- 这些生物标志物可能有助于检测Igan患者早期动脉样硬化疾病的进展.
- 进一步的研究可以验证这些发现,用于Igan的临床风险分层.
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
127
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
204
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
204
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
467
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
467
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
38
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
40
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
40
01:28Chronic Kidney Disease III: Interprofessional Care
48
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
48